Companies included in RXL
This is RXL's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–77 of 77.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| ProShares GENIUS Money Market ETF | ProShares GENIUS Money Market ETF | 100,000 | NS | 10.73092% |
| LLY | Eli Lilly & Co. | 9,065 | NS | 10.222072% |
| JNJ | Johnson & Johnson | 27,507 | NS | 7.324986% |
| ABBV | AbbVie, Inc. | 20,173 | NS | 5.018428% |
| MRK | Merck & Co., Inc. | 28,330 | NS | 3.760078% |
| UNH | UnitedHealth Group, Inc. | 10,341 | NS | 3.250796% |
| AMGN | Amgen, Inc. | 6,147 | NS | 2.557605% |
| ABT | Abbott Laboratories | 19,848 | NS | 2.475384% |
| TMO | Thermo Fisher Scientific, Inc. | 4,288 | NS | 2.395211% |
| GILD | Gilead Sciences, Inc. | 14,161 | NS | 2.260966% |
| ISRG | Intuitive Surgical, Inc. | 4,048 | NS | 2.184782% |
| N/A | N/A | 11,075 | NC | 1.925238% |
| PFE | Pfizer, Inc. | 64,898 | NS | 1.923472% |
| SYK | Stryker Corp. | 3,928 | NS | 1.63139% |
| DHR | Danaher Corp. | 7,176 | NS | 1.620253% |
| Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | 23,236 | NS | 1.553448% |
| VRTX | Vertex Pharmaceuticals, Inc. | 2,897 | NS | 1.542822% |
| MDT | Medtronic plc | 14,641 | NS | 1.532664% |
| Repurchase Agreement | Repurchase Agreement | 1,422,502.03 | PA | 1.524798% |
| MCK | McKesson Corp. | 1,409 | NS | 1.49125% |
| BSX | Boston Scientific Corp. | 16,921 | NS | 1.393893% |
| CVS | CVS Health Corp. | 14,489 | NS | 1.240923% |
| HCA | HCA Healthcare, Inc. | 1,823 | NS | 1.035085% |
| REGN | Regeneron Pharmaceuticals, Inc. | 1,151 | NS | 0.964402% |
| CI | Cigna Group (The) | 3,049 | NS | 0.947208% |
| N/A | N/A | 18,800 | NC | 0.93666% |
| COR | Cencora, Inc. | 2,213 | NS | 0.882769% |
| ELV | Elevance Health, Inc. | 2,536 | NS | 0.869879% |
| N/A | N/A | 7,700 | NC | 0.840692% |
| Repurchase Agreement | Repurchase Agreement | 704,945.4 | PA | 0.75564% |
| Repurchase Agreement | Repurchase Agreement | 704,945.4 | PA | 0.75564% |
| ZTS | Zoetis, Inc. | 5,030 | NS | 0.706855% |
| CAH | Cardinal Health, Inc. | 2,712 | NS | 0.666378% |
| IDXX | IDEXX Laboratories, Inc. | 912 | NS | 0.642009% |
| BDX | Becton Dickinson & Co. | 3,271 | NS | 0.618779% |
| EW | Edwards Lifesciences Corp. | 6,623 | NS | 0.613875% |
| N/A | N/A | 28,090 | NC | 0.610924% |
| N/A | N/A | 5,547.4 | NC | 0.520587% |
| GEHC | GE HealthCare Technologies, Inc. | 5,200 | NS | 0.469717% |
| ResMed, Inc. | ResMed, Inc. | 1,666 | NS | 0.457631% |
| Repurchase Agreement | Repurchase Agreement | 422,967.24 | PA | 0.453384% |
| Repurchase Agreement | Repurchase Agreement | 422,967.24 | PA | 0.453384% |
| A | Agilent Technologies, Inc. | 3,236 | NS | 0.421032% |
| WAT | Waters Corp. | 1,121 | NS | 0.383772% |
| Repurchase Agreement | Repurchase Agreement | 352,472.7 | PA | 0.37782% |
| IQV | IQVIA Holdings, Inc. | 1,944 | NS | 0.372604% |
| DXCM | DexCom, Inc. | 4,455 | NS | 0.350656% |
| BIIB | Biogen, Inc. | 1,674 | NS | 0.344198% |
| MTD | Mettler-Toledo International, Inc. | 233 | NS | 0.341339% |
| STE | STERIS plc | 1,120 | NS | 0.302957% |
| Repurchase Agreement | Repurchase Agreement | 281,978.16 | PA | 0.302256% |
| Repurchase Agreement | Repurchase Agreement | 281,978.16 | PA | 0.302256% |
| LH | Labcorp Holdings, Inc. | 946 | NS | 0.293176% |
| DGX | Quest Diagnostics, Inc. | 1,270 | NS | 0.288479% |
| HUM | Humana, Inc. | 1,376 | NS | 0.281037% |
| CNC | Centene Corp. | 5,329 | NS | 0.256365% |
| ZBH | Zimmer Biomet Holdings, Inc. | 2,262 | NS | 0.238684% |
| MRNA | Moderna, Inc. | 3,968 | NS | 0.227852% |
| WST | West Pharmaceutical Services, Inc. | 821 | NS | 0.22383% |
| PODD | Insulet Corp. | 802 | NS | 0.212004% |
| VTRS | Viatris, Inc. | 13,141 | NS | 0.210304% |
| Hologic, Inc. | Hologic, Inc. | 2,540 | NS | 0.20518% |
| INCY | Incyte Corp. | 1,883 | NS | 0.204405% |
| Cooper Cos., Inc. (The) | Cooper Cos., Inc. (The) | 2,270 | NS | 0.203589% |
| ALGN | Align Technology, Inc. | 762 | NS | 0.155273% |
| Repurchase Agreement | Repurchase Agreement | 140,989.08 | PA | 0.151128% |
| UHS | Universal Health Services, Inc. | 631 | NS | 0.139401% |
| RVTY | Revvity, Inc. | 1,294 | NS | 0.136361% |
| SOLV | Solventum Corp. | 1,682 | NS | 0.133779% |
| BAX | Baxter International, Inc. | 5,867 | NS | 0.128105% |
| TECH | Bio-Techne Corp. | 1,779 | NS | 0.112509% |
| CRL | Charles River Laboratories International, Inc. | 561 | NS | 0.107334% |
| HSIC | Henry Schein, Inc. | 1,142 | NS | 0.100856% |
| MOH | Molina Healthcare, Inc. | 586 | NS | 0.096765% |
| INVESCO GOVT AND AGCY LEX | INVESCO GOVT AND AGCY LEX | 67,200 | NS | 0.072033% |
| DVA | DaVita, Inc. | 403 | NS | 0.067519% |
| N/A | N/A | 1,435 | NC | -2.855568% |
SEC N-PORT snapshot as of .